Search research articles
Contact Us
Filters
Showing results (51-60 of 134) with videos related to
Page
of 14
Sort By:
Nucleic Acids Research
|
February 21, 2022
ALT-FISH quantifies alternative lengthening of telomeres activity by imaging of single-stranded repeats
Lukas Frank, Anne Rademacher, Norbert Mücke, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification
André Oberthuer, Frank Berthold, Patrick Warnat, et al.
Oncoimmunology
|
September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
Sonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.
Archives of Toxicology
|
June 28, 2018
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
Fiona R Kolbinger, Emily Koeneke, Johannes Ridinger, et al.
Human Molecular Genetics
|
January 25, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis
Daniel Dreidax, Sina Gogolin, Christina Schroeder, et al.
International Journal of Cancer
|
July 29, 2011
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma
Sara De Brouwer, Pieter Mestdagh, Irina Lambertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Histone deacetylase 8 in neuroblastoma tumorigenesis
Ina Oehme, Hedwig E Deubzer, Dennis Wegener, et al.
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Cancer Research
|
April 29, 2010
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma
Daniel Muth, Seda Ghazaryan, Isabella Eckerle, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 134) with videos related to
Sort By:
Page
of 14
Nucleic Acids Research
|
February 21, 2022
ALT-FISH quantifies alternative lengthening of telomeres activity by imaging of single-stranded repeats
Lukas Frank, Anne Rademacher, Norbert Mücke, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification
André Oberthuer, Frank Berthold, Patrick Warnat, et al.
Oncoimmunology
|
September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
Sonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.
Archives of Toxicology
|
June 28, 2018
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
Fiona R Kolbinger, Emily Koeneke, Johannes Ridinger, et al.
Human Molecular Genetics
|
January 25, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis
Daniel Dreidax, Sina Gogolin, Christina Schroeder, et al.
International Journal of Cancer
|
July 29, 2011
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma
Sara De Brouwer, Pieter Mestdagh, Irina Lambertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Histone deacetylase 8 in neuroblastoma tumorigenesis
Ina Oehme, Hedwig E Deubzer, Dennis Wegener, et al.
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Cancer Research
|
April 29, 2010
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma
Daniel Muth, Seda Ghazaryan, Isabella Eckerle, et al.
Page
of 14